![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Hadassah Medical Organization |
---|---|
Information provided by: | Hadassah Medical Organization |
ClinicalTrials.gov Identifier: | NCT00532519 |
Prurigo nodularis (PN) is a common dermatological disorder, manifested as scaly nodules which appear mainly on the extensor surfaces of the limbs. PN may appear secondarily to skin scratching in chronic hepatitis, liver cirrhosis, uremia, hypothyroidism etc. Nevertheless, in many cases no underlying physical disease is present. According to the literature, in fifty percent of the patients there is co-morbidity with depression, anxiety or somatoform disorders.
We hypothesize that a group of these patients may benefit from antidepressant therapy.
Condition | Intervention |
---|---|
Prurigo Nodularis |
Drug: citalopram (cipralex) |
Study Type: | Interventional |
Study Design: | Open Label, Single Group Assignment |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contact: Liran Horev, MD | OO97226777111 | LIRAN_CH@BEZEQINT.NET |
Israel | |
: Hadassah Medical Organization, | |
Jerusalem, Israel |
Principal Investigator: | liran horev, md | Hadassah Medical Organization, Jerusalem, Israel |
Principal Investigator: | rena cooper-kazaz, md | Hadassah-Hebrew University Medical Center |
Study ID Numbers: | horcoop-hmo-ctil |
Study First Received: | September 19, 2007 |
Last Updated: | September 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00532519 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Skin Diseases Skin Diseases, Eczematous Dexetimide Neurodermatitis Citalopram |
Prurigo nodularis Serotonin Dermatitis Prurigo |
Parasympatholytics Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Cholinergic Antagonists Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Physiological Effects of Drugs Psychotropic Drugs Antiparkinson Agents Cholinergic Agents |
Serotonin Uptake Inhibitors Pharmacologic Actions Muscarinic Antagonists Serotonin Agents Autonomic Agents Therapeutic Uses Peripheral Nervous System Agents Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |